Eovist
Contrast Media
GuerbetPhase 4 / ApprovedActive
B
63/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 48/ 100
- Competitive Position
- 95/ 100
Competitive context
4 Active assets in the Contrast Media cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Gadobutrol Guerbet | Phase 4 | BB |
GADODIAMIDE Guerbet | Phase 4 | BB |
GADOTERIDOL Guerbet | Phase 4 | B |
Folic Acid Fuling Central Hospital of Chongqing City | Phase 2/3 | B |
Enalapril Maleate Fuling Central Hospital of Chongqing City | Phase 2/3 | B |
GADOBENATE DIMEGLUMINE Guerbet | Phase 4 | B |
Same molecule, other indications
Eovist is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →